On 5 June 2025, during the first strategic session focused on “Strengths, Weaknesses, Challenges, and Opportunities of the Lithuanian Bioeconomy System, and Its Probable and Desirable Visions for 2040”, a Memorandum of Cooperation of the Lithuanian Bioeconomy HUB was signed. The memorandum was signed by the HUB coordinator – VMU Agriculture Academy – along with three co-founding…
On April 18, the annual LithuaniaBIO General Assembly took place. During the meeting, a new board member was elected – Justinas Taruška, CEO of “Nando”, who joined the team to contribute to strategic decision-making in Lithuania’s biotechnology sector. Following the assembly, the Lithuanian Biotechnology and Life Sciences Industry Forum was held – one of many…
Launching the Diverse Gene Watch Project: Early Forecasting and Monitoring System for Genetic Biodiversity Loss in Keystone Forest Tree Species We are pleased to announce the successful launch of the Diverse Gene Watch Project, in which LithuaniaBIO is a proud partner, earlier this week in Kaunas, Lithuania.This collaborative initiative brings together six research institutions, five…
On March 18–19, LithuaniaBIO, together with Lithuanian life sciences companies – Caszyme, Nando, Biomapas, VUGENE, LAIMA and Vital 3D Technologies – participated in Advanced Therapies Congress, the largest commercial cell and gene therapy conference and exhibition in Europe, held in London. The event brought together executives and top-level leaders from ATMP (Advanced Therapy Medicinal Products)…
The establishment of the Baltic Biotechnology Hub is an ambitious initiative by life science and biotech organzations from Latvia, Lithuania and Estonia, aimed at uniting the region’s biotechnology sector and positioning the Baltic States as leaders in innovation. This hub will serve as a dynamic platform for collaboration among businesses, academia, policymakers, and society, promoting…